From today, around 300 people a year with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) – a type of non-Hodgkin lymphoma that has returned or not responded to chemotherapy – can access ...
Thousands of NHS patients are set to benefit from a major modernisation of the health service, as the government announces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback